The lung cancer diagnostic and screening market is growing rapidly as the prevalence of lung cancer continues to rise worldwide, making it one of the most pressing public health concerns. This market is driven by the demand for early detection methods and advancements in diagnostic technologies, which are crucial for improving survival rates among lung cancer patients. Screening tools, such as low-dose computed tomography (LDCT), biomarkers, and molecular diagnostics, are at the forefront of the market, helping to detect cancer at early stages when treatment options are more effective.

Mammography Market Size Was Valued at USD 2.37 Billion in 2023, and is Projected to Reach USD 5.12 Billion by 2032, Growing at a CAGR of 8.93% From 2024-2032.

The scope of the medical cyclotron market is the market that deals with the manufacture, development and distribution of cyclotron equipment, particularly for medical purposes and mainly for production of isotopes needed for diagnosis and treatment of diseases like cancer.